Three-dimensional (3D) slice-to-volume (SVR) fetal magnetic resonance imaging (MRI) has over six times the fetal optic pathway visualization rate of standard two-dimensional MRI, according to new research presented at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.
For the visualization and measurement of the fetal optic pathway, emerging research suggests that three-dimensional slice-to-volume (3D SVR) magnetic resonance imaging (MRI) may offer significant advantages over ultrasound and traditional MRI modalities.
In a summa cum laude award-winning presentation at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii, researchers compared the use of 3D SVR MRI versus traditional two-dimensional MRI for visualization of the fetal optic pathway (FOP).
The study authors reported a 78.6 percent FOP visualization rate with 3D SVR MRI (55 out of 70 cases) in comparison to 12.8 percent (9 of 70 cases) for traditional MRI. The use of 3D SVR MRI allowed researchers to measure the pre-chiasmatic optic nerve width in 96.4 percent of cases (53 of 55 cases) and the optic chiasm width in 100 percent of cases (55 of 55 cases), according to the study.
“Our preliminary results … demonstrate the promises and utility of this technique,” noted lead study author Eric Juang, M.S., a medical student at the Creighton University School of Medicine in Phoenix and radiology research associate at the Phoenix Children’s Hospital, and colleagues.
Images courtesy of the American Roentgen Ray Society.
Emphasizing that disrupted development of FOP can lead to permanent visual impairment, Juang and colleagues said 3D SVR MRI may facilitate early detection and improved outcomes.
Noting the limitations of oligohydramnios and variable reproducibility with ultrasound, and spatial resolution issues with FOP assessment on 2D fetal MRI, the researchers pointed out multiple advantages with 3D SVR MRI. Potential benefits include improved resolution that facilitates more precise FOP measurements and less susceptibility to motion artifacts, according to Juang and colleagues. They also noted that 3D SVR MRI is not affected by fetal position, which is a limitation of ultrasound assessment.
In regard to the inherent limitations of a single-center retrospective study, the researchers acknowledged the potential for bias, noting that only fetuses with suspected pathologies were referred for MRI scans. Juang and colleagues also noted that the 3D SVR MRI, which requires six or more T2-weighted single-shot fast spin-echo (SSFSE) images for reconstruction, lacks the availability of ultrasound-based approaches.
(Editor's note: For related content, see "Prospective MRI Study Reveals Impact of Opioid Exposure on the Fetal Brain.")
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
GE HealthCare Launches PET MPI Agent Flyrcado at ACC Conference
March 28th 2025The positron emission tomography myocardial perfusion imaging (PET MPI) agent, which offers a significantly higher half-life than other cardiac PET agents, was recently granted pass-through payment status by CMS that will go into effect on April 1, 2025.